Seble Wagaw

"Developing novel medicines is hard. Most of the time, compounds don’t make it all the way through to development, so to be part of a project that made it through commercial launch to have a direct impact on so many patients is incredible."

"That early read out was a sign that what we were doing was incredibly efficacious in the field."